Over the past 12 months, $VTGN has been discussed by 2 distinct FinTwit voices, accumulating 78 mentions from December 17, 2025 through May 12, 2026. The overwhelming majority of this discussion—77 mentions—came from @acinvestorblog (Antonio Costa), whose posts focused on long research. The single remaining mention came from @investmentguru_. Discussion centered on clinical trial developments and regulatory progress for VistaGen's pipeline programs.